Ainos, Inc. (NASDAQ:AIMDW) Short Interest Update

Ainos, Inc. (NASDAQ:AIMDWGet Free Report) was the target of a large decrease in short interest in January. As of January 15th, there was short interest totaling 2,955 shares, a decrease of 22.9% from the December 31st total of 3,832 shares. Based on an average daily volume of 1,244 shares, the short-interest ratio is presently 2.4 days. Based on an average daily volume of 1,244 shares, the short-interest ratio is presently 2.4 days.

Ainos Stock Down 24.9%

NASDAQ AIMDW opened at $0.12 on Friday. Ainos has a twelve month low of $0.05 and a twelve month high of $0.95. The stock has a 50-day moving average of $0.11 and a 200 day moving average of $0.18.

About Ainos

(Get Free Report)

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.

See Also

Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.